A comparative study of sequential therapy and 10-day standard triple therapy for Helicobacter pylori infection eradication: a randomized, open-label, multicentre trial in Chinese naive patients

Trial Profile

A comparative study of sequential therapy and 10-day standard triple therapy for Helicobacter pylori infection eradication: a randomized, open-label, multicentre trial in Chinese naive patients

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Esomeprazole (Primary) ; Amoxicillin; Clarithromycin; Tinidazole
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top